Lorenza Alvarez Herrero
Overview
Explore the profile of Lorenza Alvarez Herrero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
485
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Verheij E, van Munster S, Chan M, Malekzadeh A, Cotton C, Weusten B, et al.
Gastrointest Endosc
. 2025 Feb;
PMID: 39983998
Background And Aims: Endoscopic eradication therapy (EET) for Barrett's esophagus (BE) with high-grade dysplasia (HGD) aims to prevent progression to life-limiting cancer. However, HGD patients with a short life expectancy...
2.
Frederiks C, Frederiks C, Boer L, Boer L, Gloudemans B, Alvarez Herrero L, et al.
Endoscopy
. 2025 Jan;
PMID: 39855269
Although endoscopic resection (ER) is recommended as first-choice treatment for early esophageal neoplasia, patients with esophageal varices are considered a high-risk group owing to an increased risk of bleeding. This...
3.
Meulen L, Bogie R, Siersema P, Winkens B, Vlug M, Wolfhagen F, et al.
Endoscopy
. 2024 Dec;
PMID: 39653123
Background: Piecemeal endoscopic mucosal resection (EMR) of large (≥ 20 mm) nonpedunculated colorectal polyps (LNPCPs) is succeeded by a 6-month surveillance endoscopy to evaluate the post-EMR scar for recurrence. Data...
4.
Jukema J, Kusters C, Jong M, Fockens K, Boers T, van der Putten J, et al.
Gastrointest Endosc
. 2024 Apr;
100(4):616-625.e8.
PMID: 38636819
Background And Aims: Characterization of visible abnormalities in patients with Barrett's esophagus (BE) can be challenging, especially for inexperienced endoscopists. This results in suboptimal diagnostic accuracy and poor interobserver agreement....
5.
van Munster S, Verheij E, Ozdemir O, Toes-Zoutendijk E, Lansdorp-Vogelaar I, Nieuwenhuis E, et al.
Gastroenterology
. 2024 Mar;
166(6):1058-1068.
PMID: 38447738
Background & Aims: Follow-up (FU) strategies after endoscopic eradication therapy (EET) for Barrett's neoplasia do not consider the risk of mortality from causes other than esophageal adenocarcinoma (EAC). We aimed...
6.
van Tilburg L, Verheij E, van de Ven S, van Munster S, Weusten B, Alvarez Herrero L, et al.
Endoscopy
. 2024 Feb;
56(8):559-568.
PMID: 38378018
Background: This study evaluated the proportion of patients with residual neoplasia after endoscopic resection (ER) for Barrett's neoplasia with confirmed tumor-positive vertical resection margin (R1v). Methods: This retrospective cohort study...
7.
Meulen L, Bogie R, Siersema P, Winkens B, Vlug M, Wolfhagen F, et al.
Gut
. 2024 Jan;
73(5):741-750.
PMID: 38216328
Objective: Endoscopic mucosal resection (EMR) is the preferred treatment for non-invasive large (≥20 mm) non-pedunculated colorectal polyps (LNPCPs) but is associated with an early recurrence rate of up to 30%....
8.
Fockens K, Jukema J, Boers T, Jong M, van der Putten J, Pouw R, et al.
United European Gastroenterol J
. 2023 Apr;
11(4):324-336.
PMID: 37095718
Introduction: Endoscopic detection of early neoplasia in Barrett's esophagus is difficult. Computer Aided Detection (CADe) systems may assist in neoplasia detection. The aim of this study was to report the...
9.
Frederiks C, van Munster S, Nieuwenhuis E, Alvarez Herrero L, Alkhalaf A, Schenk B, et al.
Clin Gastroenterol Hepatol
. 2022 Nov;
21(9):2260-2269.e9.
PMID: 36423874
Background & Aims: Although random histological sampling from the esophagogastric junction (EGJ) after complete eradication of Barrett's esophagus (BE) is recommended, its clinical relevance is questionable. This study aimed to...
10.
Nieuwenhuis E, van Munster S, Curvers W, Weusten B, Alvarez Herrero L, Bogte A, et al.
Endoscopy
. 2022 Aug;
54(10):C15.
PMID: 35931066
No abstract available.